Drugs / TAF
last change Dec 2025 re-read 2 minutes ago

TAF

Developed for
hepatitis B virus infection
Investigated by
Sun Yat-sen University

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT07253220 Dec 2025 → Sep 2027 expected hepatitis B virus infection, hepatocellular carcinoma Sun Yat-sen University Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TAF ClinicalTrials.gov intervention name — accepted as the source's own label NCT07253220